Our partnership with npower

Over the last 13 years, npower has contributed £10.5 million to help 34,000 families affected by cancer.

Nearly 1 in 3 people diagnosed with cancer say they feel the cold more (Source: Macmillan/YouGov, 2017). The side effects of treatment – like weight or hair loss – can make it harder to keep warm, meaning you often need to turn the heat up. This can have an impact on energy bills, at a time when it may be impossible to work. That’s why we’re working with npower to help people living with cancer keep warm without worrying about the cost.

An image of a woman with short hair sat at a computer. One the back of her chair is a jacket with the words 'We are Macmillan. Cancer support' on it.

Macmillan and npower in partnership

Macmillan and npower in partnership

npower supports their customers who are living with cancer by capping energy bills and writing off debt through npower’s Macmillan Fund*. And they support Macmillan’s Energy Advice Team who offer guidance and help source funding for people living with cancer who are struggling to keep warm. With npower’s help, we’re also able to give out around 46 Macmillan Grants for fuel a day, worth an average of £200 each*. You don’t have to be an npower customer to receive support from our Energy Advice Team – we’re here for you no matter who supplies your gas and electricity.

Since the start of our partnership, npower employees have continued to go above and beyond, raising £3.5 million to date – enough to provide emergency energy grants for 17,500 people living with cancer.

npower infographic
npower infographic

View a large version

Read a description of this image

To hear more about how Macmillan and npower are helping people living with cancer keep warm without the worry visit macmillan.org.uk/keepwarm.

For more information about the partnership visit npower’s website.

* Eligibility criteria apply.


Source: Macmillan/YouGov online survey of 2,014 adults aged 18 and over in the UK with a previous cancer diagnosis. Fieldwork conducted between 26th April and 3rd May 2017. The figures have been weighted and are representative of the living with cancer population